Phibro Animal Health (PAHC) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $37.98, +0.13% vs the prior close of $37.93.
- Volume 184.70K shares, 0.8x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
PAHC ends flat (+0.1%) to $37.98. Closed at $37.98, +0.13% vs the prior close of $37.93. Day range $37.83–$39.64, opened at $38.19.
PAHC daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — PAHC ends flat (+0.1%) to $37.98
- Closed at $37.98, +0.13% vs the prior close of $37.93. Day range $37.83–$39.64, opened at $38.19.
- Volume was 184.70K shares, 0.8x its 50-day average of 232.71K.
- Price is +5.4% vs its 50-day average ($36.04) and -8.0% vs its 200-day average ($41.27).
- 52-week range $28.25–$60.08; today's close sits at 31% of that range, 36.8% below the 52-week high.
Oct 14, 2026 — PAHC jumps 3.0% to $37.93
- Closed at $37.93, +3.04% vs the prior close of $36.81. Day range $36.53–$38.33, opened at $36.53.
- Volume was 283.10K shares, 1.2x its 50-day average of 230.82K.
- Price is +5.4% vs its 50-day average ($36.00) and -8.1% vs its 200-day average ($41.27).
- 52-week range $28.25–$60.08; today's close sits at 30% of that range, 36.9% below the 52-week high.
Oct 13, 2026 — PAHC dips 1.7% to $36.81
- Closed at $36.81, -1.66% vs the prior close of $37.43. Day range $36.70–$37.89, opened at $37.75.
- Volume was 407.40K shares, 1.8x its 50-day average of 228.63K.
- Price is +2.3% vs its 50-day average ($35.97) and -10.8% vs its 200-day average ($41.27).
- 52-week range $28.25–$60.08; today's close sits at 27% of that range, 38.7% below the 52-week high.
Oct 12, 2026 — PAHC dips 2.3% to $37.43
- Closed at $37.43, -2.27% vs the prior close of $38.30. Day range $37.05–$38.65, opened at $38.28.
- Volume was 205.90K shares, 0.9x its 50-day average of 228.62K.
- Price is +4.0% vs its 50-day average ($35.98) and -9.3% vs its 200-day average ($41.27).
- 52-week range $28.25–$60.08; today's close sits at 29% of that range, 37.7% below the 52-week high.
Oct 9, 2026 — PAHC rises 2.4% to $38.30, a 1-month high
- Closed at $38.30, +2.41% vs the prior close of $37.40. Day range $37.40–$39.26, opened at $37.40.
- Volume was 235.90K shares, 1.0x its 50-day average of 228.50K.
- Price is +6.5% vs its 50-day average ($35.96) and -7.2% vs its 200-day average ($41.27).
- 52-week range $28.25–$60.08; today's close sits at 32% of that range, 36.3% below the 52-week high.
Oct 8, 2026 — PAHC dips 0.8% to $37.40
- Closed at $37.40, -0.85% vs the prior close of $37.72. Day range $36.72–$37.58, opened at $37.53.
- Volume was 238.70K shares, 1.0x its 50-day average of 227.56K.
- Price is +4.1% vs its 50-day average ($35.92) and -9.4% vs its 200-day average ($41.27).
- 52-week range $28.25–$60.08; today's close sits at 29% of that range, 37.7% below the 52-week high.
Oct 7, 2026 — PAHC jumps 3.0% to $37.72, a 1-month high
- Closed at $37.72, +3.03% vs the prior close of $36.61. Day range $36.03–$37.92, opened at $36.43.
- Volume was 199.50K shares, 0.9x its 50-day average of 231.56K.
- Price is +5.0% vs its 50-day average ($35.91) and -8.6% vs its 200-day average ($41.27).
- 52-week range $28.25–$60.08; today's close sits at 30% of that range, 37.2% below the 52-week high.
Oct 6, 2026 — PAHC dips 1.6% to $36.61
- Closed at $36.61, -1.56% vs the prior close of $37.19. Day range $36.31–$37.70, opened at $37.46.
- Volume was 133.20K shares, 0.6x its 50-day average of 231.78K — lighter than usual.
- Price is +2.0% vs its 50-day average ($35.88) and -11.3% vs its 200-day average ($41.28).
- 52-week range $28.25–$60.08; today's close sits at 26% of that range, 39.1% below the 52-week high.
Oct 5, 2026 — PAHC ends flat (-0.1%) to $37.19
- Closed at $37.19, -0.13% vs the prior close of $37.24. Day range $37.05–$38.05, opened at $37.14.
- Volume was 280.00K shares, 1.2x its 50-day average of 228.92K.
- Price is +3.7% vs its 50-day average ($35.86) and -10.0% vs its 200-day average ($41.30).
- 52-week range $28.25–$60.08; today's close sits at 28% of that range, 38.1% below the 52-week high.
Oct 2, 2026 — PAHC jumps 3.8% to $37.24, 3 up days in a row
- Closed at $37.24, +3.82% vs the prior close of $35.87. Day range $36.19–$37.62, opened at $36.19.
- Volume was 222.70K shares, 1.0x its 50-day average of 227.71K.
- Price is +4.0% vs its 50-day average ($35.79) and -9.9% vs its 200-day average ($41.32).
- 52-week range $28.25–$60.08; today's close sits at 28% of that range, 38.0% below the 52-week high.
- That makes 3 straight gains.
PAHC latest news & SEC filings
Every SEC filing by or about PAHC in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 18, 2026 · Form ARS — Annual report to shareholders
Annual report to shareholders
Sep 18, 2026 · Form DEFA14A — Additional proxy materials
Additional proxy materials
Sep 18, 2026 · Form DEF 14A — Proxy statement
Proxy statement — agenda for the shareholder meeting (board elections, executive pay, votes)
Sep 17, 2026 · Form 4/A — Insider trade (amended)
Amended insider trade report (Form 4/A)
- David Glenn received an award of 3,482 shares on Aug 6, 2026; now holds 54,959
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 17, 2026 · Form 4/A — Insider trade (amended)
Amended insider trade report (Form 4/A)
- Miller Larry Lee received an award of 3,726 shares on Aug 6, 2026; now holds 38,275
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 16, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 26, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 26, 2026 · Form 10-K — Annual report
Annual report (audited full-year financial statements and business review)
Fiscal year ended Jun 30, 2026:
- Revenue: $1.52B (prior year $1.30B) (+17.1% vs Jun 30, 2025)
- Net income: $99.72M (prior year $48.26M) (+106.6% vs Jun 30, 2025)
- Diluted EPS: $2.43 (prior year $1.19) (+104.2% vs Jun 30, 2025)
Aug 10, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 10, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 10, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 6, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 30, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 28, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Jun 26, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Things to know before you trade PAHC
- Last results release: Aug 26, 2026 (8-K Item 2.02). Previous ones: May 6, 2026, Feb 4, 2026, Nov 5, 2025. Based on that rhythm, the next report is likely around Nov 25, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.57% (largest 3.8%).
- Liquidity: about 249.38K shares (≈$9.47M) trade per day on average.
- 52-week position: $37.98 vs a range of $28.25–$60.08 (31% of the range).
- Dividends: last ex-dividend date Sep 2, 2026 ($0.12/share); 4 payments in the past 12 months.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 1 open-market buys, 24 sales; latest: E Thomas Corcoran bought 10,000 shares on May 29, 2026.
- Latest filings: 8-K Aug 26, 2026; 10-K Aug 26, 2026; 8-K Jul 28, 2026.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
PAHC market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 38.19 | 39.64 | 37.83 | 37.98 | 184.70K |
| Oct 14, 2026 | 36.53 | 38.33 | 36.53 | 37.93 | 283.10K |
| Oct 13, 2026 | 37.75 | 37.89 | 36.70 | 36.81 | 407.40K |
| Oct 12, 2026 | 38.28 | 38.65 | 37.05 | 37.43 | 205.90K |
| Oct 9, 2026 | 37.40 | 39.26 | 37.40 | 38.30 | 235.90K |
| Oct 8, 2026 | 37.53 | 37.58 | 36.72 | 37.40 | 238.70K |
| Oct 7, 2026 | 36.43 | 37.92 | 36.03 | 37.72 | 199.50K |
| Oct 6, 2026 | 37.46 | 37.70 | 36.31 | 36.61 | 133.20K |
| Oct 5, 2026 | 37.14 | 38.05 | 37.05 | 37.19 | 280.00K |
| Oct 2, 2026 | 36.19 | 37.62 | 36.19 | 37.24 | 222.70K |
| Oct 1, 2026 | 35.58 | 36.22 | 35.18 | 35.87 | 275.00K |
| Sep 30, 2026 | 35.68 | 36.02 | 35.06 | 35.74 | 205.50K |
| Sep 29, 2026 | 35.46 | 35.72 | 34.70 | 35.45 | 170.50K |
| Sep 28, 2026 | 34.25 | 36.13 | 33.84 | 35.70 | 485.90K |
| Sep 25, 2026 | 33.93 | 34.66 | 33.52 | 34.45 | 206.60K |
| Sep 24, 2026 | 34.10 | 34.25 | 33.05 | 33.93 | 130.60K |
| Sep 23, 2026 | 35.14 | 36.04 | 34.04 | 34.10 | 141.50K |
| Sep 22, 2026 | 35.10 | 35.54 | 34.91 | 35.15 | 204.00K |
| Sep 21, 2026 | 34.71 | 35.38 | 34.46 | 34.68 | 141.30K |
| Sep 18, 2026 | 34.12 | 35.11 | 34.12 | 34.56 | 635.50K |
About Phibro Animal Health
Phibro Animal Health (PAHC) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in TEANECK, NJ. State of incorporation: DE. Fiscal year ends June 30. SEC CIK 1069899.
PAHC board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Jack Bendheim | Executive Chairman | Aug 10, 2026 |
| Jonathan Bendheim | Director | Aug 10, 2026 |
| Daniel M Bendheim | President and CEO | Aug 10, 2026 |
| E Thomas Corcoran | Director | Jun 2, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Jack Bendheim | Executive Chairman | Aug 10, 2026 |
| Daniel M Bendheim | President and CEO | Aug 10, 2026 |
| Glenn David | Chief Financial Officer | Sep 17, 2026 |
| Lisa Ann Escudero | See Remarks | Aug 10, 2026 |
| Larry Lee Miller | Chief Operating Officer | Sep 17, 2026 |
| Patrick Rodriguez | VP Finance and Treasurer | Aug 10, 2026 |
| Judith Weinstein | See Remarks | Aug 10, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| May 29, 2026 | E Thomas Corcoran | Buy | 10,000 | $31.77 |
| May 7, 2026 | Jack Bendheim | Sale | 2,029 | $49.19 |
| May 7, 2026 | Jack Bendheim | Sale | 1,149 | $48.31 |
| May 7, 2026 | Jack Bendheim | Sale | 1,350 | $47.59 |
| May 7, 2026 | Co., Llc Bfi | Sale | 2,029 | $49.19 |
| May 7, 2026 | Co., Llc Bfi | Sale | 1,149 | $48.31 |
| May 7, 2026 | Co., Llc Bfi | Sale | 1,350 | $47.59 |
| May 6, 2026 | Jack Bendheim | Sale | 5,634 | $57.18 |
| May 6, 2026 | Jack Bendheim | Sale | 1,406 | $58.13 |
| May 6, 2026 | Co., Llc Bfi | Sale | 5,634 | $57.18 |
| May 6, 2026 | Co., Llc Bfi | Sale | 1,406 | $58.13 |
| May 5, 2026 | Jack Bendheim | Sale | 6,264 | $55.73 |
| May 5, 2026 | Jack Bendheim | Sale | 776 | $56.37 |
| May 5, 2026 | Co., Llc Bfi | Sale | 6,264 | $55.73 |
| May 5, 2026 | Co., Llc Bfi | Sale | 776 | $56.37 |
PAHC financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Jun 30, 2026 | $1.52B | $99.72M | 2.43 | $68.95M |
| Jun 30, 2025 | $1.30B | $48.26M | 1.19 | $80.12M |
| Jun 30, 2024 | $1.02B | $2.42M | 0.06 | $87.59M |
| Jun 30, 2023 | $977.89M | $32.61M | 0.81 | $13.31M |
| Jun 30, 2022 | $942.26M | $49.17M | 1.21 | $31.65M |
Latest balance sheet: total assets $1.50B, total liabilities $1.12B, cash $61.42M (as of Jun 30, 2026).
PAHC earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 26, 2026 | 8-K Item 2.02 (results) | $36.09 |
| May 6, 2026 | 8-K Item 2.02 (results) | $58.50 |
| Feb 4, 2026 | 8-K Item 2.02 (results) | $41.00 |
| Nov 5, 2025 | 8-K Item 2.02 (results) | $41.15 |
| Aug 27, 2025 | 8-K Item 2.02 (results) | $32.20 |
| May 7, 2025 | 8-K Item 2.02 (results) | $19.39 |
| Feb 5, 2025 | 8-K Item 2.02 (results) | $22.37 |
| Nov 6, 2024 | 8-K Item 2.02 (results) | $23.09 |
| Aug 28, 2024 | 8-K Item 2.02 (results) | — |
| May 8, 2024 | 8-K Item 2.02 (results) | — |
| Feb 7, 2024 | 8-K Item 2.02 (results) | — |
| Nov 8, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)AbbVie (ABBV)Merck (MRK)Abbott Laboratories (ABT)Vertex Pharmaceuticals Inc / Ma (VRTX)Pfizer (PFE)Bristol Myers Squibb (BMY)Astrazeneca (AZN)Regeneron Pharmaceuticals (REGN)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on PAHC
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.